Younossi, Zobair MWong, Vincent Wai-SunAnstee, Quentin MRomero-Gomez, ManuelTrauner, Michael HHarrison, Stephen ALawitz, Eric JOkanoue, TakeshiCamargo, MarianneKersey, KathrynMyers, Robert PGoodman, ZacharyStepanova, Maria2025-01-072025-01-072020-08-28https://hdl.handle.net/10668/26242Fatigue and pruritus are common in patients with chronic liver diseases of all etiologies, but clinical awareness is mostly restricted to those with cholestatic liver diseases. We assessed the impact of fatigue and pruritus on patient-reported outcomes (PROs) of patients with advanced nonalcoholic steatohepatitis (NASH). Specifically, PROs (Short Form-36, Chronic Liver Disease Questionnaire-NASH, Euro-Qol 5 Dimension, and Work Productivity and Activity Impairment instruments) were assessed at baseline in patients with histologically confirmed bridging fibrosis (F3) or compensated cirrhosis (F4) due to NASH enrolled in STELLAR 3 and 4. Presence of fatigue and pruritus were indicated by a score of 4 or less on the respective items of the Chronic Liver Disease Questionnaire-NASH (scale range, 1-7). Among the included 1,669 patients with advanced NASH (mean age = 58 ± 9 years, 48% F3, 42% with psychiatric comorbidities), 33% and 27% had fatigue and pruritus, respectively. Patients with NASH with fatigue were younger, more likely to be female, cirrhotic, and diabetic, and had higher body mass index and more comorbidities (all P enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/research article33163834open access10.1002/hep4.15812471-254XPMC7603531https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep4.1581https://pmc.ncbi.nlm.nih.gov/articles/PMC7603531/pdf